A COMPARISON OF MADOPAR CR AND STANDARD MADOPAR IN THE TREATMENT OF NOCTURNAL AND EARLY-MORNING DISABILITY IN PARKINSONS-DISEASE

被引：0
|
作者：
不详
机构：
来源：
CLINICAL NEUROPHARMACOLOGY | 1989年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：498 / 505
页数：8
相关论文
共 50 条
  • [1] A COMPARISON OF STANDARD MADOPAR AND CONTROLLED RELEASE MADOPAR IN PARKINSONS-DISEASE
    GRAHAM, JS
    HENDERSON, JM
    MORRIS, JGL
    YIANNIKAS, C
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (01): : 11 - 15
  • [2] MADOPAR DISPERSIBLE IN THE TREATMENT OF ADVANCED PARKINSONS-DISEASE
    FORNADI, F
    MILANI, F
    WERNER, M
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S7 - S15
  • [3] EFFECTIVENESS OF MADOPAR HBS PLUS MADOPAR STANDARD IN PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE - 2 YEARS OF FOLLOW-UP
    PACCHETTI, C
    MARTIGNONI, E
    SIBILLA, L
    BRUGGI, P
    TURLA, M
    NAPPI, G
    EUROPEAN NEUROLOGY, 1990, 30 (06) : 319 - 323
  • [4] A COMPARISON OF THE EFFECTS OF CONTROLLED-RELEASE LEVODOPA (MADOPAR CR) WITH CONVENTIONAL LEVODOPA IN LATE PARKINSONS-DISEASE
    MACMAHON, DG
    SACHDEV, D
    BODDIE, HG
    ELLIS, CJK
    KENDAL, BR
    BLACKBURN, NA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (03): : 220 - 223
  • [5] PARKINSONS-DISEASE WITH DIPHASIC DYSKINESIA AND EARLY-MORNING DYSTONIA
    WAKAYAMA, Y
    NAKASHIMA, Y
    TANAKA, K
    MANO, Y
    ANDO, K
    ARCHIVES OF NEUROLOGY, 1982, 39 (08) : 531 - 531
  • [6] GROWTH-HORMONE AND PROLACTIN STIMULATION BY MADOPAR IN PARKINSONS-DISEASE
    MARTINEZCAMPOS, A
    GIOVANNINI, P
    PARATI, E
    NOVELLI, A
    CARACENI, T
    MULLER, EE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1981, 44 (12): : 1116 - 1123
  • [7] PARKINSONS-DISEASE TREATED WITH SINEMET OR MADOPAR - CONTROLLED MULTICENTER TRIAL
    PAKKENBERG, H
    BIRKETSMITH, E
    DUPONT, E
    HANSEN, E
    MIKKELSEN, B
    PRESTHUS, J
    RAUTAKORPI, I
    RIMAN, E
    RINNE, UK
    ACTA NEUROLOGICA SCANDINAVICA, 1976, 53 (05): : 376 - 385
  • [8] MADOPAR HYDRODYNAMICALLY BALANCED SYSTEM IN THE MANAGEMENT OF ON-OFF IN PARKINSONS-DISEASE
    CARTA, A
    STOCCHI, F
    RUGGIERI, S
    BARONTI, F
    BRAVI, D
    AGNOLI, A
    NEW TRENDS IN CLINICAL NEUROPHARMACOLOGY: CALCIUM ANATONISTS, ACUTE NEUROLOGY, HEADACHE AND MOVEMENT DISORDERS, 1988, 7 : 257 - 261
  • [9] IMPLICATIONS OF COMBINED TREATMENT WITH MADOPAR AND L-DEPRENIL IN PARKINSONS-DISEASE - LONG-TERM STUDY
    BIRKMAYER, W
    RIEDERER, P
    AMBROZI, L
    YOUDIM, MBH
    LANCET, 1977, 1 (8009): : 439 - 443
  • [10] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY
    BIRKMAYER, W
    KNOLL, J
    RIEDERER, P
    YOUDIM, MBH
    HARS, V
    MARTON, J
    JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) : 113 - 127
12345